Aprea Therapeutics CEO Christian Schade's 2019 pay jumps 520% to $3.7M
Aprea Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
Aprea Therapeutics reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, three executives at Aprea Therapeutics received on average a compensation package of $2.2M, a 275% increase compared to previous year.
Average pay of disclosed executives at Aprea Therapeutics
Christian S. Schade, Chief Executive Officer, received $3.7M in total, which increased by 520% compared to 2018. 82% of Schade's compensation, or $3M, was in option awards. Schade also received $210K in non-equity incentive plan and $446K in salary.
Scott M. Coiante, Chief Financial Officer, received a compensation package of $1.8M. 82% of the compensation package, or $1.5M, was in option awards.
Eyal C. Attar, Chief Medical Officer, earned $1.2M in 2019.
Related executives
You may also like
Source: SEC filing on April 29, 2020.